Brown Advisory’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.6M Buy
1,909,056
+185,326
+11% +$3.88M 0.08% 205
2026
Q1
$34.4M Buy
1,723,730
+35,374
+2% +$834K 0.06% 240
2025
Q4
$44.8M Buy
1,688,356
+428,996
+34% +$11M 0.06% 216
2025
Q3
$29.9M Buy
1,259,360
+679,335
+117% +$12.1M 0.04% 270
2025
Q2
$9.62M Buy
580,025
+29,607
+5% +$646K 0.01% 412
2025
Q1
$13.7M Buy
+550,418
New +$12.6M 0.02% 357

Other funds holding KMTS

Brown Advisory's KMTS Position: Q2 2026 in Review

Brown Advisory increased its Kestra Medical Technologies (KMTS) stake by 11% in Q2 2026, buying an estimated $3.88M and bringing the position to 1,909,056 shares worth $48.6M. The position accounts for 0.08% of the portfolio, ranked #205.

Brown Advisory first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Brown Advisory held 1,909,056 shares of Kestra Medical Technologies worth $48.6M as of Q2 2026.
  • Brown Advisory bought 185,326 Kestra Medical Technologies shares in Q2 2026, an estimated $3.88M.
  • Kestra Medical Technologies made up 0.08% of Brown Advisory's portfolio in Q2 2026, its #205 holding.
  • Brown Advisory first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.